Bank of America
IDNA icon

Bank of America’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bank of America’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
467,003
+8,306
+2% +$249K ﹤0.01% 2693
2026
Q1 		$13.3M Buy
458,697
+111,992
+32% +$3.25M ﹤0.01% 2734
2025
Q4 		$9.08M Buy
346,705
+58,538
+20% +$1.51M ﹤0.01% 2929
2025
Q3 		$6.8M Buy
288,167
+18,046
+7% +$399K ﹤0.01% 3708
2025
Q2 		$5.54M Sell
270,121
-4,870
-2% -$98.1K ﹤0.01% 3792
2025
Q1 		$5.63M Buy
274,991
+64,203
+30% +$1.43M ﹤0.01% 3690
2024
Q4 		$4.77M Sell
210,788
-117,607
-36% -$2.82M ﹤0.01% 3638
2024
Q3 		$8.08M Buy
328,395
+17,962
+6% +$438K ﹤0.01% 3265
2024
Q2 		$7.18M Buy
310,433
+44,514
+17% +$1.04M ﹤0.01% 3277
2024
Q1 		$6.4M Buy
265,919
+85,727
+48% +$2.01M ﹤0.01% 3401
2023
Q4 		$4.15M Buy
180,192
+40,012
+29% +$804K ﹤0.01% 3705
2023
Q3 		$2.85M Sell
140,180
-135,398
-49% -$3.04M ﹤0.01% 3926
2023
Q2 		$6.44M Buy
275,578
+34,865
+14% +$836K ﹤0.01% 3153
2023
Q1 		$5.6M Buy
240,713
+52,838
+28% +$1.32M ﹤0.01% 3433
2022
Q4 		$4.73M Buy
187,875
+62,759
+50% +$1.69M ﹤0.01% 3437
2022
Q3 		$3.3M Sell
125,116
-24,725
-17% -$763K ﹤0.01% 3789
2022
Q2 		$4.33M Sell
149,841
-203,149
-58% -$6.06M ﹤0.01% 3557
2022
Q1 		$12.2M Buy
352,990
+131,409
+59% +$4.64M ﹤0.01% 2671
2021
Q4 		$9.71M Sell
221,581
-95,934
-30% -$4.54M ﹤0.01% 2962
2021
Q3 		$16.1M Buy
317,515
+190,855
+151% +$9.95M ﹤0.01% 2370
2021
Q2 		$6.59M Sell
126,660
-7,524
-6% -$353K ﹤0.01% 3265
2021
Q1 		$6.13M Buy
134,184
+56,152
+72% +$2.74M ﹤0.01% 3200
2020
Q4 		$3.58M Buy
78,032
+50,842
+187% +$2.2M ﹤0.01% 3445
2020
Q3 		$1.06M Buy
27,190
+21,859
+410% +$840K ﹤0.01% 4165
2020
Q2 		$202K Buy
5,331
+4,331
+433% +$146K ﹤0.01% 5238
2020
Q1 		$27K Buy
+1,000
New +$28.4K ﹤0.01% 6076

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America's IDNA Position: Q2 2026 in Review

Bank of America increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1.8% in Q2 2026, buying an estimated $249K and bringing the position to 467,003 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Bank of America first reported a position in IDNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $16.1M in Q3 2021. 65 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Bank of America held 467,003 shares of iShares Genomics Immunology and Healthcare ETF worth $15.8M as of Q2 2026.
  • Bank of America bought 8,306 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $249K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2693 holding.
  • Bank of America first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2020 and has held it in 26 quarters since.
  • Bank of America's iShares Genomics Immunology and Healthcare ETF position peaked at $16.1M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.